Chinese drug R&D platform Yaoyanshe pockets $86m in Series C+, D

Chinese drug R&D platform Yaoyanshe pockets $86m in Series C+, D

Source: Volodymyr Hryshchenko/Unsplash

Eudora Wang

10 August, 2020

GGV CapitalpharmaceuticalSequoia Capital ChinaVision Plus CapitalYaoyanshe

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.